Challenges to environmental toxicology and epidemiology: Where do we stand and which way do we go?

Toxicology Letters

Volumn 151, Issue 1, 2004, Pages 255-266

  Pesch, B ^a   Bruning T ^a   Frentzel Beyme, R ^b   Johnen, G ^a   Harth, V ^a   Hoffmann, W ^c   Ko, Y ^d   Ranft, U ^e   Traugott, U G ^f   Thier, R ^g   Taeger, D ^a   Bolt, H M ^h  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f Europroteome AG   (Germany)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Exposure assessment; Gene environment interaction; Pathomechanism; Toxicogenomics

Indexed keywords

INDUSTRIAL CHEMICAL;

BIOINFORMATICS; CARCINOGENESIS; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; GENE INTERACTION; GENOME; GLOBAL CHANGE; HEALTH HAZARD; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ANIMALIA;

EID: 2942511504     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.02.020     Document Type: Article

References (77)

1. Agundez J.A., Gallardo L., Ledesma M.C., Lozano L., Rodriguez-Lescure A., Pontes J.C., Iglesias-Moreno M.C., Poch J., Ladero J.M., Benitez J. Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients. Oncology. 61:2001;59-63
2. Altmuller J., Palmer L.J., Fischer G., Scherb H., Wjst M. Genomewide scans of complex human diseases: true linkage is hard to find. Am. J. Hum. Genet. 69:2001;936-950
3. Bailey J.A., Gu Z., Clark R.A., Reinert K., Samonte R.V., Schwartz S., Adams M.D., Myers E.W., Li P.W., Eichler E.E. Recent segmental duplications in the human genome. Science. 297:2002a;1003-1007
4. Bailey J.A., Yavor A.M., Viggiano L., Misceo D., Horvath J.E., Archidiacono N., Schwartz S., Rocchi M., Eichler E.E. Human-specific duplication and mosaic transcripts: the recent paralogous structure of chromosome 22. Am. J. Hum. Genet. 70:2002b;83-100
5. Ballestar E., Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis. 23:2002;1103-1109
6. Benhamou S., Lee W.J., Alexandrie A.K., Boffetta P., Bouchardy C., Butkiewicz D., Brockmoller J., et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 23:2002;1343-1350
7. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 362:2003;419-427
8. Boffetta P., Burstyn I. Studies of carcinogenicity of bitumen fume in humans. Am. J. Ind. Med. 43:2003;1-2
9. Bogardus S.T. Jr., Concato J., Feinstein A.R. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. J. Am. Med. Assoc. 281:1999;1919-1926
10. Bolt H.M. Occupational versus environmental and lifestyle exposures of children and adolescents in the European Union. Toxicol. Lett. 127:2002;121-126
11. Bolt H.M. Genotoxicity - threshold or not? Introduction of cases of industrial chemicals. Toxicol. Lett. 140-141:2003;43-51
12. Bolt H.M., Roos P.H., Thier R. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int. Arch. Occup. Environ. Health. 76:2003;174-185
13. Bolt, H.M., Foth, H., Hengstler, J.G., Degen, G.H., 2004. Carcinogenicity categorization of chemicals - new aspects to be considered in a European perspective. Toxicol. Lett., this volume.
14. Brosius J. Genomes were forged by massive bombardments with retroelements and retrosequences. Genetica. 107:1999a;209-238
15. Brosius J. RNAs from all categories generate retrosequences that may be exapted as novel genes or regulatory elements. Gene. 238:1999b;115-134
16. Brüning T., Bolt H.M. Renal toxicity and carcinogenicity of trichloroethylene: key results, mechanisms, and controversies. Crit. Rev. Toxicol. 30:2000;253-285
17. Burstyn I., Boffetta P., Burr G.A., Cenni A., Knecht U., Sciarra G., Kromhout H. Validity of empirical models of exposure in asphalt paving. Occup. Environ. Med. 59:2002;620-624
18. Calabrese E.J., Baldwin L.A. Applications of hormesis in toxicology, risk assessment and chemotherapeutics. Trends Pharmacol. Sci. 23:2002;331-337
19. Caporaso N.E. Why have we failed to find the low penetrance genetic constituents of common cancers? Cancer Epidemiol. Biomarkers Prev. 11:2002;1544-1549
20. Chapman P.M. Defining hormesis: comments on Calabrese and Baldwin (2002). Hum. Exp. Toxicol. 21:2002;99-101
21. Dekant W., Koob M., Henschler D. Metabolism of trichloroethene - in vivo and in vitro evidence for activation by glutathione conjugation. Chem. Biol. Interact. 73:1990;89-101
22. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66:1981;1191-1308
23. Ducrest A.L., Szutorisz H., Lingner J., Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene. 21:2002;541-552
24. Eisen J.A., Hanawalt P.C. A phylogenomic study of DNA repair genes, proteins, and processes. Mutat. Res. 435:1999;171-213
25. EPA (Environmental Protection Agency), 1986. Guidelines for carcinogenic risk assessment. Fed. Reg., vol. 51, pp. 33992-34003.
26. EPA (Environmental Protection Agency), 1996. Guidelines for carcinogenic risk assessment. Fed. Reg., vol. 61, pp. 17960-18011.
27. Ernst M., Moolchan E.T., Robinson M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J. Am. Acad. Child Adolesc. Psychiatry. 40:2001;630-641
28. Esteller M., Herman J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 196:2002;1-7
29. European Commission, 2001. White Paper "Strategy for a future chemicals policy". Brussels.
30. Feo S., Antona V., Cammarata G., Cavaleri F., Passantino R., Rubino P., Giallongo A. Conserved structure and promoter sequence similarity in the mouse and human genes encoding the zinc finger factor BERF-1/BFCOL1/ZBP-89. Biochem. Biophys. Res. Commun. 283:2001;209-218
31. Garcia-Closas M., Thompson W.D., Robins J.M. Differential misclassification and the assessment of gene-environment interactions in case-control studies. Am. J. Epidemiol. 147:1998;426-433
32. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment? Cancer Epidemiol. Biomarkers Prev. 10:2001;1233-1237
33. Gaspari L., Marinelli D., Taioli E. International collaborative study on genetic susceptibility to environmental carcinogens (GSEC): an update. Int. J. Hyg. Environ. Health. 204:2001;39-42
34. Goeptar A.R., Commandeur J.N., van Ommen B., van Bladeren P.J., Vermeulen N.P. Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem. Res. Toxicol. 8:1995;3-21
35. Goodman J.I., Watson R.E. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 42:2002;501-525
36. Greaves M. Cancer causation: the Darwinian downside of past success? Lancet Oncol. 3:2002;244-251
37. Guengerich F.P. The Environmental Genome Project: functional analysis of polymorphisms. Environ. Health Perspect. 106:1998;365-368
38. Hamilton M.L., Guo Z., Fuller C.D., Van Remmen H., Ward W.F., Austad S.N., Troyer D.A., Thompson I., Richardson A. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res. 29:2001;2117-2126
39. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
40. Hayflick L. Mortality and immortality at the cellular level. A review. Biochemistry. 62:1997;1180-1190
41. Hengstler J.G., Bogdanffy M.S., Bolt H.M., Oesch F. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. Annu. Rev. Pharmacol. Toxicol. 43:2003;485-520
42. Hirschhorn J.N., Lohmueller K., Byrne E., Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 4:2002;45-61
43. Houlston R.S. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics. 10:2000;105-114
44. Ingelman-Sundberg M. Duplication, multiduplication, and amplification of genes encoding drug-metabolizing enzymes: evolutionary, toxicological, and clinical pharmacological aspects. Drug Metab. Rev. 31:1999;449-459
45. Jedrychowski, W., et al. (Eds.), 1999. Challenges to epidemiology in changing Europe. In: Proceedings of the Conference, Kraków, Poland, 2-3 July 1999.
46. Kitchin K.T. Defining, explaining and understanding hormesis. Hum. Exp. Toxicol. 21:2002;105-106
47. Ko Y., Abel J., Harth V., Brode P., Antony C., Donat S., Fischer H.P., Ortiz-Pallardo M.E., Thier R., Sachinidis A., Vetter H., Bolt H.M., Herberhold C., Bruning T. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res. 61:2001;4398-4404
48. Leffondre K., Abrahamowicz M., Siemiatycki J., Rachet B. Modeling smoking history: a comparison of different approaches. Am. J. Epidemiol. 156:2002;813-823
49. Lewis J., Bird A. DNA methylation and chromatin structure. FEBS Lett. 285:1991;155-159
50. Mannetje A.t'., Steenland K., Attfield M., Boffetta P., Checkoway H., DeKlerk N., Koskela R.S. Exposure-response analysis and risk assessment for silica and silicosis mortality in a pooled analysis of six cohorts. Occup. Environ. Med. 59:2002;723-728
51. McPherson J.D., Marra M., Hillier L., Waterston R.H., Chinwalla A., Wallis J., Sekhon M., et al. A physical map of the human genome. Nature. 409:2001;934-941
52. Michnea A., Gherhes I. Impact of metals on the environment due to technical accident at Aurul Baia Mare, Romania. Int. J. Occup. Med. Environ. Health. 14:2001;255-259
53. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer. 94:2001;153-156
54. Patel H.R., Hewer A., Phillips D.H., Hayes J.D., Wolf C.R., Campbell F.C. Metabolic competence and susceptibility of intestinal epithelium to genotoxic injury during regeneration. Carcinogenesis. 18:1997;2171-2177
55. Perera F.P., Weinstein I.B. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. Chronic Dis. 35:1982;581-600
56. Pesch B., Bruening T., Frentzel-Beyme R., Harth V., Hoffmann W., Ko Y., et al. Challenges to molecular epidemiology: the promise of the European Research Area. Eur. Epimarker. 7:2003;1-5
57. Pesch, B., Düsing, R., Rabstein, S., Harth, V., Grentrup, D., Brüning, T., Landt, O., Vetter, H., Ko, Y.-D., 2004. Polymorphic metabolic susceptibility genes and longevity: a study in octogonarians. Toxicol. Lett., this volume.
58. Reid G., Denger S., Kos M., Gannon F. Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. Cell. Mol. Life Sci. 59:2002;821-831
59. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517
60. Schmidt C.W. Answering the endocrine test questions. Environ. Health Perspect. 107:1999;A458-A460
61. Schott K., Raulf-Heimsoth M., Angerer J., Hahn J.U., Heger M., Preuss R., Rode P., Rühl R. Auffälligkeiten bei einer Gussasphaltkolonne - Ursachenklärung einer erhöhten PAK-Belastung. Arbeitsmed. Sozialmed. Umweltmed. 38:2003;594-597
62. Schwender, H., Zucknick, M., Ickstadt, K, Bolt, H.M., 2004. A pilot study on the application of statistical classification procedures to molecular epidemiological data. Toxicol. Lett., this volume.
63. Semple C.A., Morris S.W., Porteous D.J., Evans K.L. Computational comparison of human genomic sequence assemblies for a region of chromosome 4. Genome Res. 12:2002;424-429
64. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 71:2002;1296-1302
65. Simonato L., Agudo A., Ahrens W., Benhamou E., Benhamou S., Boffetta P., Brennan P., Darby S.C., Forastiere F., Fortes C., Gaborieau V., Gerken M., Gonzales C.A., Jockel K.H., Kreuzer M., Merletti F., Nyberg F., Pershagen G., Pohlabeln H., Rosch F., Whitley E., Wichmann H.E., Zambon P. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int. J. Cancer. 91:2001;876-887
66. Soussi T., Dehouche K., Beroud C. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum. Mutat. 15:2000;105-113
67. Steenland K., Mannetje A., Boffetta P., Stayner L., Attfield M., Chen J., Dosemeci M., DeKlerk N., Hnizdo E., Koskela R., Checkoway H. Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study. Cancer Causes Control. 12:2001;773-784
68. Stikkers D.E. Octane and the environment. Sci. Total Environ. 299:2002;37-56
69. Thier R., Bolt H.M. The new era of toxicology. Trends Pharmacol. Sci. 11:2001;549-550
70. Thier R., Golka K., Brüning T., Ko Y., Bolt H.M. Genetic susceptibility to environmental toxicants: the interface between human and experimental studies in the development of new toxicological concepts. Toxicol. Lett. 127:2002;321-327
71. Thier R., Brüning T., Roos P.H., Rihs H.-P., Golka K., Ko Y., Bolt H.M. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int. J. Hyg. Environ. Health. 06:2003;149-171
72. Vijg J., Dolle M.E. Large genome rearrangements as a primary cause of aging. Mech. Ageing Dev. 123:2002;907-915
73. Vogt A., Pesch B., Lyesnykh T., Rautiu R., Troitsky V., Magazanik D., Mamberova Ch. The risk of cyanide in gold leaching on health and environment. Eur. Epimarker. 7:2003;1-7
74. Wakefield J. Environmental genome project: focusing on differences to understand the whole. Environ. Health Perspect. 110:2002;A757-A759
75. Weiner A.M., Deininger P.L., Efstratiadis A. Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information. Annu. Rev. Biochem. 55:1986;631-661
76. Xiong W., Hsieh C.C., Kurtz A.J., Rabek J.P., Papaconstantinou J. Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucleic Acids Res. 29:2001;3087-3098
77. Zhang K., Calabrese P., Nordborg M., Sun F. Haplotype block structure and its applications to association studies: power and study designs. Am. J. Hum. Genet. 71:2002;1386-1394